Valeant Pharmaceuticals Intl (TSE: VRX) has recently received a number of price target changes and ratings updates:

  • 11/28/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$39.00 price target on the stock.
  • 11/18/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$39.00 price target on the stock.
  • 11/10/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at TD Securities from C$38.50 to C$18.00. They now have a “hold” rating on the stock.
  • 11/9/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at Scotiabank from C$32.00 to C$17.00. They now have a “sector perform” rating on the stock.
  • 11/9/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at Royal Bank Of Canada from C$47.00 to C$39.00. They now have a “sector perform” rating on the stock.
  • 11/1/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at Scotiabank from C$34.00 to C$32.00. They now have a “sector perform” rating on the stock.
  • 10/31/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$47.00 price target on the stock.
  • 10/25/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$46.50 price target on the stock.
  • 10/11/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$35.00 price target on the stock, down previously from C$36.00.
  • 10/3/2016 – Valeant Pharmaceuticals Intl had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$46.00 price target on the stock.

Valeant Pharmaceuticals Intl Inc (TSE:VRX) traded down 7.85% on Wednesday, reaching $21.24. 2,778,991 shares of the company’s stock were exchanged. Valeant Pharmaceuticals Intl Inc has a one year low of $18.41 and a one year high of $165.77. The firm has a 50 day moving average of $26.29 and a 200-day moving average of $31.45. The stock’s market cap is $7.38 billion.

Valeant Pharmaceuticals International, Inc is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices).

Receive News & Ratings for Valeant Pharmaceuticals Intl Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals Intl Inc and related companies with MarketBeat.com's FREE daily email newsletter.